Zomedica Corp. (ZOMDF): Nasdaq/NYSE listing notice — Zomedica delisted from NYSE American, to trade on OTCQB starting March 5 under ZOMDF

Zomedica Corp.

NYSE American suspended trading March 4, 2025 due to low share price under Section 1003(f)(v).
Company expects trading on OTCQB under symbol ZOMDF effective March 5, 2025.
CEO Larry Heaton stated disappointment but emphasized focus on growth and pipeline.
Company will continue to file periodic reports with the SEC and meet regulatory requirements.
Transition does not affect business or operations; real-time trading data remains available via OTC Markets.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Zomedica Corp. received a nyse_american delisting notice notice regarding minimum bid price (rules 1003(f)(v)).

Exchange: nyse american
Notice: delisting notice
Deficiency: minimum bid price
Rules: 1003(f)(v)

Exact text from the filing

March 4, 2025, Zomedica Corp. (the “ Company ”) was notified by The NYSE American LLC (“ NYSE American ”) that as a result of the Company’s previously disclosed noncompliance with Section 1003(f)(v) of the NYSE American Company Guide whereby the Company’s common shares were trading for a substantial period of time at a low price per share, NYSE American has suspended trading in the Company’s common shares as of March 4, 2025. NYSE American further indicated that it will apply to the Securities and Exchange Commission (the “ SEC ”) to delist the Company’s common shares upon completion of all ap

View on SEC.gov

Browse all listing & compliance notices →

Zomedica Corp. filing history →

Source: SEC EDGAR

accession 0001654954-25-002296

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.